Group 1 - The NASDAQ ended a five-week losing streak with a gain of 1.5% during the holiday-shortened trading week ending February 20th, indicating a rebound in the market [1] - The software sector, which had been underperforming, has shown signs of recovery, contributing to the overall market advance [1] - Bret Jensen, a market analyst with over 13 years of experience, focuses on high beta sectors in the biotech industry, aiming to identify significant investment opportunities [1] Group 2 - The Biotech Forum, led by Bret Jensen, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live discussions and weekly research updates [1]

Group 1 - iREIT+HOYA Capital focuses on income-producing asset classes that provide sustainable portfolio income, diversification, and inflation hedging [1] - The strategy emphasizes buying quality value stocks that are overlooked by the market, which can lead to significant returns [2] - The article highlights the importance of performing due diligence and making independent investment decisions [3] Group 2 - Seeking Alpha clarifies that past performance does not guarantee future results and that no specific investment recommendations are provided [4]